Fidaxomicin is available for oral administration as 200 mg tablets and as granules for oral suspension (40 mg/mL (200 mg/5 mL) when reconstituted). Fidaxomicin is administered orally with or without food.
The recommended dosage for adults is one 200 mg Fidaxomicin tablet orally twice daily for 10 days.
The recommended dosage for pediatric patients weighing at least 12.5 kg and able to swallow tablets is one 200 mg Fidaxomicin tablet administered orally twice daily for 10 days. If unable to swallow tablets, pediatric patients may be dosed with Fidaxomicin oral suspension as recommended in Table 1 below.
FDA,2020.05
Fidaxomicin is a cutting-edge antibiotic developed by Optimer that specializes in refractory Clostridium infections and ushers a new chapter in anti-infective therapy by inhibiting···【more】
Article source:Lucius LaosRelease date:2024-08-29Recommended:119
Fidaxomicinis an innovative macrolide antibiotic developed by Optimer, which has demonstrated excellent efficacy and safety by blocking bacterial RNA polymerase for the targeted tr···【more】
Article source:Lucius LaosRelease date:2024-08-29Recommended:117
Fidaxomicin is a macrolide antibiotic from Optimer, which brings an efficient and safe treatment regimen for patients with refractory Clostridium infection with its unique RNA poly···【more】
Article source:Lucius LaosRelease date:2024-08-29Recommended:153
Fidaxomicin, a potent macrolide antibiotic, is primarily utilized in the treatment of infections attributed to specific bacterial strains, serving as a pivotal therapeutic agent ag···【more】
Article source:Lucius LaosRelease date:2024-08-05Recommended:107
Fidaxomicinis a macrolide antibiotic that plays a role in the treatment of Clostridium difficile associated diarrhea (CDAD) by inhibiting the bacterial RNA polymerase to combat ref···【more】
Article source:Lucius LaosRelease date:2024-08-05Recommended:118
Fidaxomicin exerts its pharmacological effects primarily through the inhibition of bacterial RNA polymerase and is frequently prescribed for the treatment of diarrheal episodes att···【more】
Article source:Lucius LaosRelease date:2024-08-05Recommended:124
DIFICID is a medication used to treat Clostridium difficile associated diarrhea, and its use in specific populations requires particular caution.Use in Specific Populations?For cer···【more】
Article source:Lucius LaosRelease date:2024-08-05Recommended:143
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: